Fitbit appoints JMDC as exclusive Fitbit premium distributor in Japan

Date: 2020-11-27   Author: Saipriya Iyer  Category: #news

Fitbit appoints JMDC as exclusive Fitbit premium distributor in Japan

Fitbit, a renowned American consumer electronics and fitness company, has reportedly announced that JMDC would now be the exclusive distributor of Fitbit premium for its enterprise customers throughout Japan.

Since 2016, JMDC, which holds the mantle of one of the largest medical database providers in Japan, has provided Fitbit devices to its valuable enterprise customers and would now offer Fitbit Premium to its enterprise customers.

Fitbit Premium gives personalized and actionable guidance to assist people stay active, eat well, and sleep better. The membership of Fitbit Premium comprises of new challenges, health reports, workouts, novel key health metrics, personal insights, customized programs, advanced analytics and many more features all in just one app.

As a part of this new deal, the company would further provide localized programs in Japanese language for mind-fullness, nutrition, and better sleep from partners like Neurospace, Croix, and Asken. Within a year of its launch, Fitbit Premium has managed to successfully sigh on approximately 500,000 paid subscribers.

As per Ministry of Health, Labor, and Welfare, Japan continues to see rise in healthcare expenditure, with an approximate ¥42.6 trillion or US$ 385.9 billion spent on healthcare in 2018 for supporting a growing elderly population.

Steve Morley, VP of International Health Solutions & General Manager APAC, Fitbit, stated that with a leading partner like JMDC and the firm’s network of distributors, Fitbit has altogether made an important step towards making health & wellness easily achievable as well as accessible for each individual in Japan.

Morley further added that by growing its partnership with JMDC, the firm would be able to offer additional support as well as motivation to help in driving positive health-based results for a greater number of people.

Matsushima Yosuke, CEO & President, JMDC, stated that the company is thrilled to enter into a strategic partnership deal with Fitbit, a global market leader in the field of wearable devices. With the rapid growth of corporate wellness, also known as ‘Kenko-Keiei’ across Japan, the firm is able to offer more advanced wearable solutions than ever seen before.

Source credit: https://www.businesswire.com/news/home/20201125005608/en/Fitbit-and-JMDC-Sign-Agreement-to-Appoint-JMDC-as-Exclusive-Distributor-of-Fitbit-Premium-for-Enterprise-Customers-in-Japan



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Leaded Disc MOV Market 2021-2027 Detailed Analysis and Growth Strategies, Regional and Recent Scenario Analysis

Author: Sachin Pashte

Decoding Covid-19 impact on Leaded Disc MOV market over 2021-2027, with report inclusions as growth determinants, challenges, and revenue generating prospects.

The recent study on Leaded Disc MOV market is compiled with an objective to a...


Plastic Pre-Filled Syringes Sales Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2027

Author: Sachin Pashte

Market Study Report adds a new research on Global Plastic Pre-Filled Syringes Sales Market for the period of 2021-2027 that shows the growth of the market is rising at a Steady CAGR to 2027.

The recent study on Plastic Pre-Filled Syringe...


Clindamycin Phosphate and Benzoyl Peroxide Sales market to showcase strong CAGR between 2027 and 2027

Author: Sachin Pashte

Primary aspects discussed in Clindamycin Phosphate and Benzoyl Peroxide Sales market research report: profit margins, pricing models, production and consumption volume, demand and supply trends, COVID-19 impact.

The recent study on Clind...